Form 13D Athira Pharma For: 23 December
- Investing.com
- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Athira Pharma Inc (ATHA)
Assess today's live Athira Pharma Inc (ATHA) share price, performance and insights using our live NASDAQ: ATHA stock exchange data.
Analyse the historical data and Athira Pharma Inc share price performance charts on this page. Our technical summary section provides analysis on Athira Pharma share price buy/sell indicators using real-time data (or discuss the Athira Pharma (ATHA) stock price today with other investors in the Athira Pharma NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ ATHA share price (ISIN: US04746L2034) to enhance your trading decisions with our free investment tools and resources.
What Is the Athira Pharma Inc Share Price Today?
The Athira Pharma share price today is 7.510.
What Is the Stock Symbol for Athira Pharma Inc
The stock symbol (or 'ticker') for Athira Pharma Inc is "ATHA."
What Stock Exchange Does Athira Pharma Inc Trade On?
Athira Pharma Inc is listed and trades on the NASDAQ stock exchange.
Is Athira Pharma Inc a Good Stock to Buy?
Determining whether Athira Pharma Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and Athira Pharma Inc share price performance charts on this page. Our technical summary section provides analysis on Athira Pharma share price buy/sell indicators using real-time data (or discuss the Athira Pharma (ATHA) stock price today with other investors in the Athira Pharma NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ ATHA share price (ISIN: US04746L2034) to enhance your trading decisions with our free investment tools and resources.
What Is the Athira Pharma Inc Share Price Today?
The Athira Pharma share price today is 7.510.
What Is the Stock Symbol for Athira Pharma Inc
The stock symbol (or 'ticker') for Athira Pharma Inc is "ATHA."
What Stock Exchange Does Athira Pharma Inc Trade On?
Athira Pharma Inc is listed and trades on the NASDAQ stock exchange.
Is Athira Pharma Inc a Good Stock to Buy?
Determining whether Athira Pharma Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
NASDAQ
Currency in USD
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
7.060
7.770
52 wk Range
2.195
8.360
ATHA is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
7.0607.770
52 wk Range
2.1958.360
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
ATHA Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Neutral
Price Target
4.000
Downside
-46.74%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Net income is expected to grow this year
- Form 13G Athira Pharma Inc. For: 18 December
- Investing.com
- Form 13G Athira Pharma For: 23 December
- Investing.com
- Form 13D Athira Pharma For: 22 December
- Investing.com
- Form 13D Athira Pharma For: 23 December
- Investing.com
- Form 13G Athira Pharma For: 23 December
- Investing.com
- Form 13D Athira Pharma For: 22 December
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Athira Pharma Company Profile
Athira Pharma, Inc., clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. Its product pipeline includes ATH-1105 for the treatment of amyotrophic lateral sclerosis, which is in phase 1 clinical trial; ATH-1020 for the treatment of neurodegenerative diseases, which is phase 1 clinical trial, as well as early compounds which is in preclinical phase. The company was formerly known as M3 Biotechnology, Inc. and changed its name to Athira Pharma, Inc. in April 2019. Athira Pharma, Inc. was incorporated in 2011 and is headquartered in Bothell, Washington.
Athira Pharma Inc SWOT Analysis
ALS Drug Promise | Athira Pharma's ATH-1105 shows potential in ALS treatment, with positive preclinical data and Phase 1 results driving future clinical plans |
Financial Crossroads | Despite $37M cash reserves, Athira faces financial challenges. Market cap decline to $9.8M reflects investor caution amid strategic shifts |
Strategic Pivot | Explore Athira's strategic review process and pursuit of partnerships to accelerate ATH-1105 development and enhance shareholder value |
Market Sentiment | Analyst ratings hold at "Market Perform" without price targets, reflecting cautious optimism as Athira advances its focused ALS program |
Compare ATHA to Peers and Sector
Metrics to compare | ATHA | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipATHAPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.8x | −1.0x | −0.6x | |
PEG Ratio | −0.01 | 0.02 | 0.00 | |
Price/Book | 1.1x | 1.3x | 2.6x | |
Price / LTM Sales | - | 2.1x | 3.2x | |
Upside (Analyst Target) | −45.9% | 171.7% | 41.8% | |
Fair Value Upside | Unlock | 47.4% | 5.1% | Unlock |
Analyst Ratings
0 Buy
2 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Neutral
Analysts 12-Month Price Target:
Average 4.000
(-46.74% Downside)
Earnings
Latest Release
Nov 06, 2025
EPS / Forecast
-1.68 / -0.13
Revenue / Forecast
-- / --
People Also Watch
FAQ
What Is the Athira Pharma (ATHA) Share Price Today?
The live Athira Pharma share price today is 7.510
What Stock Exchange Does Athira Pharma (ATHA) Trade On?
Athira Pharma is listed and trades on the Nasdaq Stock Exchange.
What Is the Ticker (Stock Symbol) for Athira Pharma?
The stock symbol (also called a 'ticker') for Athira Pharma is "ATHA."
What Is the Current Athira Pharma Market Cap?
As of today, Athira Pharma market capitalisation is 29.62M.
What Is Athira Pharma's (ATHA) Earnings Per Share (TTM)?
The Athira Pharma EPS is currently -9.66 (Trailing Twelve Months).
When Is the Next Athira Pharma Earnings Date?
Athira Pharma's next earnings report will be released on 06 Nov 2025.
Is ATHA a Buy or Sell From a Technical Analyst Perspective?
Based on today's Athira Pharma moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Athira Pharma Stock Split?
Athira Pharma has split 1 times. (See the ATHA stock split history page for full effective split date and price information.)
How Many Employees Does Athira Pharma Have?
Athira Pharma has 26 employees.
What is the current trading status of Athira Pharma (ATHA)?
As of 24 Dec 2025, Athira Pharma (ATHA) is trading at a price of 7.510, with a previous close of 7.400. The stock has fluctuated within a day range of 7.060 to 7.770, while its 52-week range spans from 2.195 to 8.360.
What Is Athira Pharma (ATHA) Price Target According to Analysts?
The average 12-month price target for Athira Pharma is USD4, with a high estimate of USD4 and a low estimate of USD4. 0 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Neutral. The stock has an -46.74% Downside potential.
What Is the ATHA Premarket Price?
ATHA's last pre-market stock price is 7.300. The pre-market share volume is 5,870.000, and the stock has decreased by -0.100, or -1.350%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.